| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.8 |